Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 12/20 | 0.60 |
| ▸ | MMP13 | P45452 | 7/20 | 0.49 |
| ▸ | MMP2 | P08253 | 6/20 | 0.49 |
| ▸ | MMP3 | P08254 | 4/20 | 0.49 |
| ▸ | MMP9 | P14780 | 4/20 | 0.49 |
| ▸ | MMP8 | P22894 | 4/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | MMP14 | P50281 | 6/20 | 0.44 |
| ▸ | ADAMTS4 | O75173 | 2/20 | 0.41 |
| ▸ | ADAMTS5 | Q9UNA0 | 2/20 | 0.41 |
| ▸ | MEP1B | Q16820 | 1/20 | 0.41 |
| ▸ | RNF4 | P78317 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7303599 | 0.91 | MMP1 (0.49) | MMP1MMP13MMP2MMP3MMP9 | |
| SCHEMBL7308395 | 0.89 | MMP1 (0.48) | MMP1MMP13MMP2MMP3MMP9 | |
| SCHEMBL7301981 | 0.89 | MMP1 (0.61) | MMP1MMP13MMP2MMP3MMP9 | |
| SCHEMBL7306362 | 0.89 | MMP1 (0.49) | MMP1MMP13MMP2MMP3MMP9 | |
| SCHEMBL7305353 | 0.88 | MMP1 (0.48) | MMP1MMP13MMP2MMP3MMP9 | |
| SCHEMBL7298947 | 0.88 | MMP1 (0.47) | MMP1MMP13MMP2MMP3MMP9 | |
| SCHEMBL7311858 | 0.85 | MMP1 (0.45) | MMP1MMP13MMP2MMP3MMP9 | |
| SCHEMBL7298907 | 0.84 | MMP1 (0.42) | MMP1MMP13ALDH1A1 | |
| SCHEMBL7311124 | 0.81 | MMP1 (0.41) | MMP1MMP13MMP2MMP3MMP9 | |
| SCHEMBL7347267 | 0.79 | MMP1 (0.47) | MMP1MMP13MMP2MMP3MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0780386-B1 | Matrix metalloprotease inhibitors | HOFFMANN LA ROCHE (CH) | 2002-10-02 | — | — | EP | disclosed |
| US-5932595-A | ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT | SYNTEX (U.S.A.) INC. (US) | 1999-08-03 | — | — | US | disclosed |
| EP-0780386-A1 | Matrix metalloprotease inhibitors | F. HOFFMANN-LA ROCHE AG (CH) | 1997-06-25 | — | — | EP | disclosed |